(Q34377314)

1 August 2017

1 reference

title

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system (English)

1 reference

1 August 2017

0 references

1 reference

Steinman L

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

299-302

1 reference

What is the basis for HLA-DQ associations with autoimmune disease?

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Apoptosis in brain-specific autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Infection and multiple sclerosis: a possible role for superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Primary biliary cirrhosis: the molecule and the mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

A population-based study of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Genetic factors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Presenting an odd autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Major T-cell responses in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981107-1

7 January 2021

10.1016/S0092-8674(00)81107-1

Identifiers

DOI

1 reference

1 August 2017

1 reference